Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Hyrimoz
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Hyrimoz 40mg/0.8ml solution for injection pre-filled pens
1001030S0BEAAAB
|
Hyrimoz | Adalimumab | Musculoskeletal and Joint Diseases | 1 |
|
Hyrimoz 40mg/0.4ml inj pre-filled syringes
1001030S0BEADAE
|
Hyrimoz | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Hyrimoz 40mg/0.4ml solution for injection pre-filled pens
1001030S0BEACAD
|
Hyrimoz | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Hyrimoz 40mg/0.8ml inj pre-filled syringes
1001030S0BEABAA
|
Hyrimoz | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.